Abstract

Parkinson’s disease (PD) is a neurodegenerative disorder that affects millions worldwide, characterized by the progressive loss of dopaminergic neurons in the brain. While the exact cause remains elusive, researchers have made significant strides in understanding the underlying mechanisms and potential treatments. Among these treatments, brain stimulation has emerged as a promising therapeutic approach, particularly in the early stages of the disease. However, the effectiveness of such stimulation crucially depends on identifying the precise targets within the brain.